Global Markets
Viiv Healthcare, owned by GSK (GSK LN), announced its long-acting HIV treatment Cabenuva meets primary endpoint of superior viral suppression in people with viremia
StockNow breaking-news AI analysis
ViiV Healthcare announced Cabenuva met its primary endpoint for superior viral suppression in people with viremia, but retrieved evidence lacks supporting trial details.
Related stocks
1 stocksWhat do investors think?
Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactionsStockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.
